Multiple mechanisms of thrombosis complicating atherosclerotic plaques

被引:36
作者
Libby, P [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA
关键词
acute coronary syndromes; plaque; thrombosis; platelet;
D O I
10.1002/clc.4960231103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is a highly prevalent disorder and remains a leading cause of morbidity and mortality in the United States. Recent advances in vascular biology have led to a better understanding of the mechanisms underlying atherogenesis. The central role played by plaque disruption, and by adhesion, activation, and aggregation of platelets that trigger activation of the coagulation cascade in the pathogenesis of acute thrombotic events is also better understood. Combination antithrombotic therapy targeting Various platelet activation mechanisms and the coagulation cascade may help optimize the management of atherosclerosis.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 27 条
[1]   Thrombosis in ischemic heart disease [J].
Ambrose, JA ;
Weinrauch, M .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (13) :1382-1394
[2]  
Bata I, 1997, CIRCULATION, V96, P769
[3]  
BIZZOZERO J., 1882, Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin, V90, P261, DOI DOI 10.1007/BF01931360
[4]  
COLLER BS, 1991, HEART CARDIOVASCULAR, P219
[5]  
DAVIES MJ, 1990, CIRCULATION, V82, P38
[6]   CORONARY PLAQUE DISRUPTION [J].
FALK, E ;
SHAH, PK ;
FUSTER, V .
CIRCULATION, 1995, 92 (03) :657-671
[7]   Immune regulation by CD40 and its ligand GP39 [J].
Foy, TM ;
Aruffo, A ;
Bajorath, J ;
Buhlmann, JE ;
Noelle, RJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :591-617
[8]   IMMUNE-MECHANISMS IN ATHEROSCLEROSIS [J].
HANSSON, GK ;
JONASSON, L ;
SEIFERT, PS ;
STEMME, S .
ARTERIOSCLEROSIS, 1989, 9 (05) :567-578
[9]   Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women [J].
Hu, FB ;
Stampfer, MJ ;
Manson, JE ;
Grodstein, F ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (08) :530-537
[10]  
Kinlay S, 1998, J CARDIOVASC PHARM, V32, pS62